2022
What Explains Changes in Availability of Specialty Mental Health Services in Organized Settings?
NEWTON H, HUMENSKY J, GOLDMAN H, BUSCH S. What Explains Changes in Availability of Specialty Mental Health Services in Organized Settings? Milbank Quarterly 2022, 100: 1166-1191. PMID: 36575952, PMCID: PMC9836237, DOI: 10.1111/1468-0009.12592.Peer-Reviewed Original ResearchConceptsSerious mental illnessCommunity mental health facilitiesMental health servicesMental health facilitiesMedicaid expansionEmergency walkPsychotropic medicationsHealth facilitiesNational Mental Health Services SurveyHealth servicesMental illnessSpecialty mental health organizationsSpecialty mental health servicesMental health service availabilityExpansion statesNon-Medicaid expansion statesAssertive community treatmentHealth service availabilityMedicaid expansion statesNew payment modelsCommunity outpatient settingsHealth Services SurveyFacility ownership typeFacility ownershipSupport services
2020
National Trends in Outpatient Mental Health Service Use Among Adults Between 2008 and 2015
Germack HD, Drake C, Donohue JM, Golberstein E, Busch SH. National Trends in Outpatient Mental Health Service Use Among Adults Between 2008 and 2015. Psychiatric Services 2020, 71: 1127-1135. PMID: 32907475, PMCID: PMC7877566, DOI: 10.1176/appi.ps.201900576.Peer-Reviewed Original ResearchConceptsMental health outpatient visitsSpecialty mental health providersPrimary care physiciansMental health visitsOutpatient visitsPsychological distressHealth visitsOutpatient mental health service useOutpatient mental health visitsMental health service useOutpatient mental health servicesRepresentative Medical Expenditure Panel SurveyPatients' psychological distressHealth service useMedical Expenditure Panel SurveyMental health servicesBivariate logistic regressionType of treatmentHealth Workforce StudiesMental health providersHigh psychological distressPercentage of adultsProportion of respondentsCare physiciansPsychotropic medications
2016
Examining psychotropic medication use among youth in the U.S. by race/ethnicity and psychological impairment
Cook BL, Carson NJ, Kafali EN, Valentine A, Rueda JD, Coe-Odess S, Busch S. Examining psychotropic medication use among youth in the U.S. by race/ethnicity and psychological impairment. General Hospital Psychiatry 2016, 45: 32-39. PMID: 28274336, PMCID: PMC7598773, DOI: 10.1016/j.genhosppsych.2016.12.004.Peer-Reviewed Original ResearchConceptsPsychotropic medication useMedication usePsychotropic medicationsPsychological impairmentClinical practice guidelinesHealth status characteristicsRisk-benefit ratioMedical Expenditure Panel SurveyMental health disordersLogistic regression modelsRace/ethnicityMedication prescriptionsPoor medicationPractice guidelinesMedicationsHealth disordersEthnic groupsEthnic disparitiesWhite youthImpairmentStatistical differenceCareful evaluationEthnic differencesAccurate targetingRegression models